Potent Inhibition of CTLA-4 Expression by an Anti-CTLA-4 Ribozyme

By Cepero E.   Hnatyszyn H.J.   Kraus G.   Lichtenheld M.G.  

Biochemical and Biophysical Research Communications, Vol. 247, Iss. 3, 1998-06 ,pp. : 838-843

Elsevier

Access to resources Recommend Favorite

Techniques update: Crossreactivity of anti-dual-phosphorylated antibodies with actin

By Martn-Blanco E.   Martinez-Arias A.   Jarvis B.  

Trends in Cell Biology, Vol. 8, Iss. 10, 1998-10 ,pp. : 419-419

Elsevier

Access to resources Recommend Favorite

An Mse I RFLP in the Human CTLA4 Promotor

By deichmann K.   Heinzmann A.   Bruggenolte E.   Forster J.   Kuehr J.  

Biochemical and Biophysical Research Communications, Vol. 225, Iss. 3, 1996-08 ,pp. : 817-818

Elsevier

Access to resources Recommend Favorite

Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer

By Di Maio Massimo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 9, 2011-09 ,pp. : 1131-1133

Informa Healthcare

Access to resources Recommend Favorite

Molecular Weights of CTLA-4 and CD80 by Sedimentation Equilibrium Ultracentrifugation

By Fairman R.   Fenderson W.   Hail M.E.   Wu Y.   Shaw S-Y.  

Analytical Biochemistry, Vol. 270, Iss. 2, 1999-06 ,pp. : 286-295

Elsevier

Access to resources Recommend Favorite